Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M107266200 on August 20, 2001

J. Biol. Chem., Vol. 276, Issue 42, 38755-38761, October 19, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/42/38755    most recent
M107266200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berdiev, B. K.
Right arrow Articles by Benos, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berdiev, B. K.
Right arrow Articles by Benos, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

pH Alterations "Reset" Ca2+ Sensitivity of Brain Na+ Channel 2, a Degenerin/Epithelial Na+ Ion Channel, in Planar Lipid Bilayers*

Bakhrom K. BerdievDagger , Timothy B. Mapstone§, James M. Markert, G. Yancey Gillespie, Jason LockhartDagger ||, Catherine M. FullerDagger , and Dale J. BenosDagger **

From the Departments of Dagger  Physiology and Biophysics and  Surgery, University of Alabama at Birmingham, Birmingham, Alabama 35294-0005 and the § Department of Neurosurgery, Emory University, Atlanta, Georgia 30322

Received for publication, July 31, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Members of the degenerin/epithelial Na+ channel superfamily of ion channels subserve many functions, ranging from whole body sodium handling to mechanoelectrical transduction. We studied brain Na+ channel 2 (BNaC-2) in planar lipid bilayers to examine its single channel properties and regulation by Ca2+. Upon incorporation of vesicles made from membranes of oocytes expressing either wild-type (WT) BNaC-2 or BNaC-2 with a gain-of-function (GF) point mutation (G433F), functional channels with different properties were obtained. WT BNaC-2 resided in a closed state with short openings, whereas GF BNaC-2 was constitutively activated; a decrease in the pH in the trans compartment of the bilayer activated WT BNaC-2 and decreased its permeability for Na+ over K+. Moreover, these maneuvers made the WT channel more resistant to amiloride. In contrast, GF BNaC-2 did not respond to a decrease in pH, and its amiloride sensitivity and selectivity for Na+ over K+ were unaffected by this pH change. Buffering the bathing solutions with EGTA to reduce the free [Ca2+] to <10 nM increased WT single channel open probability 10-fold, but not that of GF BNaC-2. Ca2+ blocked both WT and GF BNaC-2 in a dose- and voltage-dependent fashion; single channel conductances were unchanged. A drop in pH reduced the ability of Ca2+ to inhibit these channels. These results show that BNaC-2 is an amiloride-sensitive sodium channel and suggest that pH activation of these channels could be, in part, a consequence of H+ "interference" with channel regulation by Ca2+.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Amiloride-sensitive sodium channels were initially thought to be restricted to sodium-reabsorbing epithelia such as urinary bladder, renal collecting tubules, and gastric mucosa (1, 2). However, following the cloning of the first subunit of the epithelial Na+ channel (ENaC)1 in 1993 (3, 4) and the subsequent development of specific immunological and molecular biological reagents, a new gene superfamily of ion channels was quickly defined (5, 6). Members of this degenerin/ENaC superfamily include the mammalian, avian, and amphibian orthologs of ENaC; subfamily members in snails and insects; and the genes and coding proteins involved in touch sensation and neurodegeneration in the nematode Caenorhabditis elegans (7). Over 60 members of this gene superfamily have been identified to date (8). Thus, these channels participate in a myriad of biological processes and are found not only in epithelia, but also in lymphocytes, muscle, endothelia, testes, oocytes, arterial baroreceptors, neurons, and astrocytes. Dysfunction of these channels has been implicated in several human diseases, including Liddle's disease (9-12), pseudohypoaldosteronism type 1 (13-15), cystic fibrosis (16, 17), respiratory distress syndrome (18), and influenza (19).

Acid-sensing ion channels (ASICs; otherwise known as brain Na+ channels (BNaCs)) compose one branch of the degenerin/ENaC superfamily (20). The polypeptide is predicted to have two hydrophobic domains, a large extracellular loop, and intracellularly located amino and carboxyl termini. These channels are found throughout the nervous system and were first discovered in sensory neurons (21, 22). However, their localization is not restricted to the nervous system, but extends to tissues such as the small intestine, lung, and pituitary gland (23-25). The fact that lowering extracellular pH activates the majority of these channels led to the hypothesis that they are involved in nociception (8, 26). Moreover, evidence exists suggesting that these channels may serve as mechanosensors (27, 28).

BNaC-1 (MDEG, BNC1, or ASIC-2a) and BNaC-2 (ASIC-1a), or brain sodium channels, have been cloned from mammalian brain and studied in heterologous expression systems (20-22). The major goal of this work was to characterize the single channel properties of BNaC-2 in planar lipid bilayers so that the regulatory properties of these channels could be studied in a controlled environment. Calcium caused a voltage-dependent block of both wild-type (WT) BNaC-2 and gain-of-function (GF) BNaC-2 in dose-dependent manner. At lower pH, these channels became less sensitive to the inhibitory effects of Ca2+. This "shift" in Ca2+ sensitivity at lower pH might be responsible for pH activation of BNaCs.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Planar Lipid Bilayer Experiments-- Planar lipid bilayers were formed from a solution containing a 2:1 mixture of diphytanoylphosphatidylethanolamine and diphytanoylphosphatidylserine dissolved in n-octanol at a concentration of 25 mg/ml. Membranes were painted onto a 200-µm diameter hole in a polystyrene cup. Membrane capacitance in all of the experiments reported herein averaged 250-350 picofarads. The standard bathing solution contained in both compartments of the bilayer system was composed of 100 mM sodium chloride plus 10 mM MOPS/Tris buffer (pH 7.4). Lipids were purchased from Avanti Polar Lipids (Alabaster, AL). All solutions were made using Milli-Q water and were filtered-sterilized using 0.22-µm Sterivex-GS filters (Millipore Corp., Bedford, MA). Free Ca2+ concentrations were adjusted using appropriate EGTA/Ca2+ combinations calculated by the Bound-and-Determined program (29) and were verified by Fura-2 fluorometry. Current measurements were made with a high-gain operational amplifier connected to a 10-gigaohm feedback resistor as described previously (30). Electrical connections were made through Ag/AgCl electrodes using M KCl and 3% agar bridges. Voltage was applied to the cis chamber, and the trans chamber was held at virtual ground. Oocyte membrane vesicles were applied to a preformed bilayer with a glass rod from the trans compartment with the membrane potential held at -40 mV. In most cases, the channels were oriented with the amiloride-sensitive extracellular side facing the trans solution and the cytoplasmic side facing the cis solution. Only membranes containing a single ion channel were used for experimentation. Data analysis was performed as previously described (30). Membrane vesicles from oocytes injected with water did not produce currents with properties of BNaC-2.

Oocyte Membrane Preparation-- Standard methods for oocyte isolation, cRNA preparation, and injection were applied (31-33). Briefly, eggs were removed from anesthetized frogs (Xenopus laevis) and stored in nominally Ca2+-free OR-2 solution (82.5 mM NaCl, 2.4 mM KCl, 1.0 mM MgCl2, and 5.0 mM Na-HEPES (pH 7.5)). Stage V-VI oocytes were isolated and defolliculated manually. The defolliculated oocytes were transferred to L15 medium modified for use with amphibian cells and supplemented with gentamycin sulfate (25 mg/ml). Oocytes were permitted to recover overnight at 19 °C before injection. cRNA was transcribed from appropriately linearized vectors using either T7 or SP6 polymerase promoters.

Pipettes for microinjecting cRNA were pulled and beveled. Individual oocytes were injected with cRNA for BNaC-2 (25 ng in 50 nl of water). Control injections consisted of 50 nl of RNase-free water. Injected oocytes were kept in 24-well cell culture plates containing modified L15 media in groups of three to six oocytes/well at 19 °C for 2-3 days to allow for channel synthesis and insertion. Membrane vesicles were prepared following the method of Perez et al. (34). 30 or 40 oocytes were washed in a high-potassium/sucrose medium containing the following protease inhibitors: 25 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml pepstatin, 1 mM phenylmethylsulfonyl fluoride, and 2.0 µg/ml DNase I. Oocyte membranes were isolated by discontinuous sucrose gradient density centrifugation and resuspended in 300 mM sucrose, 100 mM KCl, and 5.0 mM MOPS (pH 6.8). Membrane vesicles were separated into 50-µl fractions and stored at -80 °C until used.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Single channel traces of WT BNaC-2 incorporated into planar lipid bilayers at neutral or acidic extracellular pH are shown in Fig. 1a. When bathed in 100 mM NaCl, these channels displayed a conductance of 20 picosiemens; and at neutral pH, they were only open an average 8% of the time. However, lowering the trans solution pH to 6.2 caused the channel to remain open >90% of the time (Po = 0.90 ± 0.08, n = 10). Fig. 1b shows the effects of amiloride on WT BNaC-2 activity at pH 6.2. Amiloride produced a flickery block of the channel, consistent with its effects on other members of the degenerin/ENaC family (35-37). Fig. 1c summarizes amiloride dose-response curves of the channel at these two pH values. At pH 7.4, the apparent equilibrium inhibitory dissociation constant (Ki) for amiloride was 0.82 ± 0.09 µM (n = 7). At pH 6.2, the curve was slightly right-shifted, with Ki = 2.0 ± 0.23 µM (n = 6). There was no indication that lowering the extracellular pH changed the conductance or produced a time-dependent ion activation or inactivation of channel activity (see "Discussion"). Under asymmetric solutions of NaCl, WT BNaC-2 displayed a permeability (P) PNa/PCl ratio of 9:1 (n = 5) (data not shown). This cation/anion ratio was not altered by pH changes.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Single channel recordings of WT BNaC-2 reconstituted into planar lipid bilayers. Bilayers were bathed with symmetrical 100 mM NaCl and 10 mM MOPS. The holding potential was +100 mV, referred to the virtually grounded trans chamber. For illustration purposes, records shown were digitally filtered at 100 Hz using pCLAMP software (Axon Instruments, Inc.) subsequent to acquisition of the analog signal, which was filtered at 300 Hz with an 8-pole Bessel filter before acquisition and sampled at 1 ms/point. a, typical records of WT BNaC-2 activity recorded at pH 7.4 and 6.2 are shown. b, the effect of 1 µM amiloride on WT BNaC-2 activity at pH 6.2 is shown. c, amiloride dose-response curves of WT BNaC-2 at pH 7.4 (open circles) and pH 6.2 (closed circles) are shown. Solid lines in the graph are best fits of the experimental data points to the Michaelis-Menten equation rewritten as Po = Po(max)·(1 - [amiloride]/Ki + amiloride). d, shown are single channel current-voltage relationships of WT BNaC-2 reconstituted into planar lipid bilayers under symmetrical (circles) and bi-ionic (squares) conditions at different pH values. Data points and error bars represent means ± S.D. of at least six separate experiments. Bathing solutions contained 100 mM NaCl (cis), 100 mM NaCl (trans), and 10 mM MOPS (circles) and 100 mM KCl (cis), 100 mM NaCl (trans), and 10 mM MOPS (squares).

Fig. 1d presents a summary of the results of experiments in which WT BNaC-2 was examined for its ability to discriminate between Na+ and K+ at neutral and acid extracellular pH values. The opened and closed circles represent the current-voltage curves obtained under symmetrical conditions of NaCl and different pH values. The cis solutions of the same bilayer containing the channel were then replaced with 100 mM KCl either at pH 7.4 (open squares) or with the external solution reduced to pH 6.2 (closed squares), and bi-ionic reversal potentials were measured. The reversal potential at pH 7.4 under bi-ionic conditions was ~50 mV; using the Goldman-Hodgkin-Katz formulation, this translated into a PNa/PK of 7:1. However, when the external pH was lowered to 6.2, the reversal potential shifted to 18 mV, indicating that the relative Na+ versus K+ permeability ratio was reduced to 2.0.

Genetic studies in C. elegans have identified specific mutations in proteins homologous to the mammalian BNaCs that produce neurodegeneration (38-44). Because these same mutations that cause neurodegeneration in C. elegans have been shown to activate BNaCs in heterologous expression systems (22, 45-47), we tested whether or not the same mutation could produce a constitutive activation of BNaC-2 in bilayers. Fig. 2 presents the results of these experiments. Substituting a phenylalanine for glycine at position 433 of BNaC-2 resulted in constitutive activation of the channel, increasing Po from 0.08 ± 0.03 in the WT channel to 0.89 ± 0.09 (n = 5). The channel's sensitivity to amiloride (Fig. 2, b and c) was slightly right-shifted compared with the WT channel (~2.5 µM versus 0.8 µM at pH 7.4). However, this constitutively activated channel was insensitive to reduction of extracellular pH (Fig. 2a, lower trace). Also, acidification did not change the Ki for amiloride (Ki = 2.55 ± 0.20 µM at pH 7.4 (n = 8) versus Ki = 2.45 ± 0.24 µM at pH 6.2) of this gain-of-function mutation, in contrast to the WT channel. Another difference between G433F BNaC-2 and the WT channel was the poor ability of the mutant to discriminate between Na+ and K+, PNa/PK = 2.5:1. PNa/PK was determined from reversal potential measurements under bi-ionic conditions, which were not affected by acidification (Fig. 2d).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 2.   Single channel characteristics of G433F BNaC-2 reconstituted into planar lipid bilayers. Bilayers were bathed with symmetrical 100 mM NaCl and 10 mM MOPS. The holding potential was +100 mV, referred to the virtually grounded trans chamber. For illustration purposes, records shown were digitally filtered at 100 Hz using pCLAMP software (Axon Instruments, Inc.) subsequent to acquisition of the analog signal, which was filtered at 300 Hz with an 8-pole Bessel filter before acquisition and sampled at 1 ms/point. a, typical records of G433F BNaC-2 activity recorded at pH 7.4 and 6.2 are shown. b, the effect of 1 µM amiloride on G433F BNaC-2 activity at pH 7.4 is shown. c, amiloride dose-response curves of G433F BNaC-2 at pH 7.4 (open circles) and pH 6.2 (closed circles) are shown. Solid lines in the graph are best fits of the experimental data points to the Michaelis-Menten equation rewritten as Po = Po(max)·(1 - [amiloride]/Ki + [amiloride]). d, shown are single channel current-voltage relationships of G433F BNaC-2 reconstituted into planar lipid bilayers under symmetrical (circles) and bi-ionic (squares) conditions at different pH values. Data points and error bars represent means ± S.D. of at least five separate experiments. Bathing solutions contained 100 mM NaCl (cis), 100 mM NaCl (trans), and 10 mM MOPS (circles) and 100 mM KCl (cis), 100 mM NaCl (trans), and 10 mM MOPS (squares).

To determine the relationship between the pH and Po of BNaC-2, we performed additional pH clamp experiments. The single channel activities of both WT BNaC-2 and G433F BNaC-2 were measured under conditions in which the pH of the trans bathing compartment was varied. These results are summarized in Fig. 3. Acidification of the bathing solution increased the activity of WT BNaC-2. In contrast, the Po of constitutively activated G433F BNaC-2 was unaffected by alterations in pH, at least over the pH range 6.2-7.4.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of pH on the single channel open probability of WT BNaC-2 and G433F BNaC-2 incorporated into planar lipid bilayer membranes. Each point represents the mean ± S.D. of at least three experiments.

All of the aforementioned sets of experiments were performed with ~10 µM Ca2+ in the bilayer bathing solution. Because the role of Ca2+ in modulating native and cloned epithelial Na+ channels is well established (48-51), we next tested the hypothesis that Ca2+ may influence the activity of BNaC-2.

Fig. 4 displays current traces of WT BNaC-2 at pH 7.4 in a planar lipid bilayer. In Fig. 4a, the upper trace was obtained under control conditions in which the channel was bathed with standard 100 mM NaCl solution containing ~10 µM Ca2+ as determined by Fura-2 measurements. Buffering the solutions bathing both sides of the bilayer with EGTA to be nominally free of Ca2+ (lower trace) increased the open probability of BNaC-2 (from 0.08 ± 0.02 to 0.91 ± 0.08 (n = 8)). Subsequent elevation of the concentration of Ca2+ in either compartment of the bilayer chamber resulted in a dose-dependent decrease in Po, but not in the unitary conductance of the channel. In Fig. 4a, the effects of increasing the cis Ca2+ concentration (either 5, 10, or 25 µM) on the single channel activity are shown. A comparable outcome was observed when addition of Ca2+ was made to the trans compartment of the bilayer chamber, albeit with a different dose dependence (Fig. 4, b and c). Also, the efficacy of both cis and trans Ca2+ as blockers of BNaC-2 was dependent upon membrane voltage (Fig. 4d).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of [Ca2+] on WT BNaC-2 reconstituted into planar lipid bilayers at pH 7.4. a, the first trace shows a typical current record in the presence of ~10 µM Ca2+. When 100 µM EGTA was added to both sides (second trace), the channel open probability increased dramatically. Subsequent additions of Ca2+ to the cis compartment reduced the single channel open probability (third through fifth traces). The records are shown for +100 mV. b, shown is the open probability as a function of the log of the trans Ca2+ concentration. c, shown is the single channel open probability as a function of the log of the cis Ca2+ concentration at -100 and +100 mV. d, shown is the effect of the cis or trans Ca2+ concentration on the voltage dependence of trans Ki(Ca) and cis Ki(Ca). Data points and error bars indicate means ± S.D. of at least six independent experiments.

trans and cis Ca2+ dose-response curves at holding potentials of -100 and +100 mV are shown in Fig. 4 (b and c, respectively). Fitting the experimental data to the Michaelis-Menten equation transformed for open probabilities allowed the calculation of [Ca2+] required for half-maximal inhibition of the channels (Ki(Ca)). The trans Ki(Ca) was 51.3 ± 6.9 µM (n = 7) at +100 mV and 2.4 ± 0.36 µM (n = 7) at -100 mV; the cis Ki(Ca) was 1.4 ± 0.21 µM (n = 9) at +100 mV and 35.6 ± 5.4 µM (n = 7) at -100 mV. Fig. 4d presents a semilogarithmic plot of cis and trans Ki(Ca) as a function of applied membrane voltage. The lines through the data points were computed from the Woodhull formulation (52) using a best fit approach and varying delta  in the Woodhull equation, KD(V) = KD(0)·exp(delta ·z·F·V/R·T), where KD(V) and KD(0) are Ca2+ inhibitory dissociation constants at given and zero holding potentials, respectively; delta  is the fraction of the electric distance between the surface of the channel and the binding site; z is the valence of the blocker; and T, F, V, and R have their usual meanings.

An assumption utilizing this equation is that the binding sites for Ca2+ are located within the electric field. From these plots, there was an inverse voltage dependence between cis and trans inhibition of BNaC-2 by Ca2+, suggesting a minimum of two binding sites within the electric field. The locations of these sites computed by this equation are at 18 ± 1.9 and 20 ± 2.1% of the electric field from the cis and trans surfaces of the channel, respectively. Thus, we conclude that our results are consistent with the hypothesis that Ca2+ directly blocks BNaC-2 in a manner similar to that of the rat epithelial sodium channel and in a manner similar to that of amiloride-sensitive channels recorded in native epithelial cells (48-50).

As described above, a decrease in pH resulted in some changes in the basic biophysical profile (e.g. ion selectivity and amiloride inhibition) of BNaC-2 activity. These changes prompted us to test the possibility that the effects of trans and cis Ca2+ could be different on BNaC-2 activity at decreased pH. Fig. 5 presents a similar analysis done for the WT channel at pH 6.2. Buffering the bilayer bathing solution to be nominally free (<10 nM) of Ca2+ with EGTA had little effect on the open probability of the channel (Fig. 5a). However, increasing the concentrations of Ca2+ in either the cis or trans compartment reduced the single channel open probability in a dose-dependent fashion. Fig. 5 (b and c) presents the trans and cis Ca2+ dependence at -100 and +100 mV. Compared with pH 7.4, the effectiveness of either cis or trans Ca2+ as an inhibitor of channel activity was diminished by nearly an order of magnitude at either +100 or -100 mV at lower pH. The voltage dependence at pH 6.2 of the Ca2+ block of BNaC-2 is shown in Fig. 5d. The apparent electrical distances for Ca2+ from both the cis and trans solutions were the same as determined at pH 7.4, viz. 18 and 20%, respectively. The simplest explanation for these observations is that hydrogen ions compete for Ca2+ by binding to the same sites.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of [Ca2+] on WT BNaC-2 reconstituted into planar lipid bilayers at pH 6.2. a, the first trace shows a typical current record in the presence of ~10 µM Ca2+. Subsequent to 100 µM EGTA (<10 nM free Ca2+) addition to both compartments (second trace), the open probability did not change significantly. Subsequent additions of Ca2+ to the cis compartment reduced single channel activity in a concentration-dependent fashion (third through fifth traces). The records are shown for +100 mV. b, shown is the single channel open probability as a function of the log of the trans Ca2+ concentration at -100 and +100 mV. c, shown is the single channel open probability as a function of the log of the cis Ca2+ concentration at -100 and +100 mV. d, shown is the effect of the cis or trans Ca2+ concentration on the voltage dependence of trans Ki(Ca) and cis Ki(Ca). Data points and error bars indicate means ± S.D. of at least six independent experiments.

The effects of cis and trans Ca2+ on the activity of G433F BNaC-2 at pH 7.4 and 6.2 were also examined. These experiments are summarized in Table I. Because this mutant channel was constitutively activated, buffering the bathing solution to <10 nM free Ca2+ with EGTA had no significant effect on Po at either pH 7.4 or 6.2 (data not shown). Addition of Ca2+ to either the cis or trans compartment produced a voltage- and concentration-dependent decrease in Po. Table I summarizes these data and provides a comparison with the WT channel. The major effect of this GF mutation was to reduce the effectiveness of Ca2+ in blocking the channel at all applied voltages and at both pH values. The locations within the electric field of both the cis and trans Ca2+-binding sites were unaffected by the G433F mutation.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Ca2+ inhibitory constants for WT BNaC2 and GF BNaC2 at different voltages and pH values in planar lipid bilayers


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

BNaC-2 Forms a Functional Channel in Bilayers-- We have examined BNaC-2, a member of the degenerin/ENaC superfamily of ion channels, using a model planar lipid bilayer approach. Both WT BNaC-2 and GF BNaC-2 formed functional amiloride-sensitive Na+ channels. Decreasing the pH had a differential effect on their biophysical properties. A decrease in pH activated a predominantly closed WT channel, but had little or no influence on constitutively activated GF BNaC-2. Also, a decrease in pH resulted in slight rightward shift of amiloride sensitivity (~0.8 µM at pH 7.4 versus ~2 µM at pH 6.2) and decreased the ability of WT BNaC-2 to select between Na+ and K+ (from PNa/PK = 7:1 at pH 7.4 to PNa/PK = 2:1 at pH 6.2). These maneuvers with pH had no effect on the amiloride sensitivity (~2.5 µM) and cation selectivity of GF BNaC-2. The fact that the introduction of the GF point mutation in the pre-M2 region of BNaC-2 resulted in changes in channel activity and selectivity may be indicative of involvement of this residue in pore and/or selectivity filter formation. In fact, mutation at a similar position in MDEG (BNaC-1) led to a change in ion selectivity and conductance (22) and pH sensitivity (47). Lazdunski and co-workers (22, 47) consider this residue to be part of an inhibitory domain rather than part of the pore lining. They proposed that steric constraints or activation by yet unidentified mechanisms open the channel. In another report, acidification made this residue susceptible to chemical modification (45). It was proposed that a lowered pH induces a conformational change, "locking" the channel in the open state. Our observation of changes in GF BNaC-2 activity and selectivity favors the possibility of participation of this residue in the lining of the pore, perhaps as part of a selectivity loop, by analogy to the region preceding the first transmembrane domain of ASIC-2 (53). Alternatively, either low pH or the GF mutation alters gating of BNaC-2 to create a high-Po state, which obligatorily diminishes Na+ selectivity.

Some differences in channel characteristics between the bilayer studies and those reported using heterologous expression systems are noted. First, in the bilayer system, even under basal conditions, a low level of WT channel activity is seen. This may result from the fact that the surface pH in negatively charged bilayers of the type used in these experiments would produce a more acidic pH at the membrane-solution interface. Based on the surface charge distribution of phosphatidylethanolamine/phosphatidylserine bilayers, we calculate (using a charge density of one charge/120 A) from the Gouy-Chapman theory (54) that the surface pH should be ~6.6, giving a channel open probability of 0.4-0.5. Recently, de Weille et al. (55) reported spontaneous channel activity at pH ~7.3 in outside-out membrane patches excised from COS-7 cells transfected with human ASIC-3. Second, once a WT channel is activated by pH, the channel stays activated as long as the pH is maintained at acidic levels. In heterologous expression systems, the current activation is transient (8). These observations suggest that there may be modifier protein(s) associated with the channels in native or expressed cell systems that inactivate the channels. This possibility is also underscored by the fact that members of this branch of the degenerin/ENaC superfamily can associate with each other (56-58)2 and ENaC (21)2 to form a functional channel. This observation further complicates the physical picture of the channel and its potential interaction with any cellular binding partners. Needless to say, the cell-free bilayer system is devoid of such potential modifier proteins. Third, GF mutations of MDEG-1 are more sensitive to amiloride and pH than GF BNaC-2 incorporated in the bilayer (47). Correspondingly, mutation of the Drosophila Ripped Pocket (RPK(A523V)) protein also significantly increases the sensitivity of the current to amiloride (59). These results are in contrast to what was observed in the bilayer, viz. a reduced sensitivity to amiloride. The reason for these discrepancies is not known, but probably relates to more complex effects of amiloride on BNaCs (60). Alternatively, the introduction of particular amino acids could affect amiloride sensitivity because substitution of valine for glycine at position 430 of BNC-1 does indeed reduce sensitivity to amiloride (46). In addition to GF mutations, pH modification of the channel activity could, at least in part, contribute to an uncontrollable influx of cations, leading to osmotic disturbances that ultimately can cause degeneration of the cell.

Decreases in pH Desensitize BNaC-2 to Ca2+-- Ca2+ can influence a wide variety of cellular events, and adequate operation of ion channels is not an exception. ASIC (also called ASIC-1a, ASIC-alpha , and BNaC-2) is permeable to calcium ions, but increasing extracellular calcium concentrations become inhibitory (61, 62). This is not the case for its splice variant, ASIC-beta (63), although Sutherland et al. (62) reported inhibition of ASIC-1b (also called ASIC-beta in Ref. 63) by Ca2+. This discrepancy is explained by different pH measurements and/or single amino acid differences in the clones used (62). Additionally, different concentrations of Ca2+ were used in these studies (500 µM versus 10 mM). Ca2+ is also able to block currents generated by coexpression of ASIC-2 and ASIC-3 subunits without being permeant (64). ASIC-1a currents are potentiated if extracellular Ca2+ is raised from 2 to 10 mM, whereas both ASIC-2a and ASIC-1a plus ASIC-2a currents are partially blocked; Na+ remained the principal conducting ion (65). Also, Ca2+ induced a decrease in unitary currents of both ASIC-1a (BNaC-2) and ASIC-2a (BNaC-1). It was suggested that open channel probability increases due to recruitment of rundown channels by Ca2+. Interpretation of the data in these studies was confounded by the natural complexity of the cell machinery. Using the planar lipid bilayer approach allowed us to minimize changes in these variables such as cellular pH, membrane voltage, and number of channels.

Our results indicate a direct modulation of BNaC-2 activity by cis and trans Ca2+, although we cannot rule out the possibility that other physiological constituents can take part in this process (49, 66, 67). These possibilities are not necessarily mutually exclusive; different modes of regulation may be operational under given circumstances.

This study also establishes the exact range of concentrations at which either cis or trans Ca2+ blocks brain sodium channels. The Ki for intracellular (i.e. cis) Ca2+ at -100 mV was ~36 µM at pH 7.4. For the constitutively activated single point mutant BNaC-2 channel (i.e. G433F BNaC-2), the Ki for intracellular Ca2+ increased to 122 µM. For both the WT and mutant channels, decreasing the pH to 6.2 made Ca2+ a less effective blocker; the Ki values for cis Ca2+ were increased to 469 µM and 1.45 mM for WT BNaC-2 and G433F BNaC-2, respectively. These results suggest a competition between protons and Ca2+ ions. A decrease in pH is a well established feature of ischemia (68). Even though mild acidosis has been considered neuroprotective (69), its role in cell survival or death is not fully understood. Also, intracellular Ca2+ overload has been implicated as a possible mechanism of neuronal injury in ischemia (70, 71). Moreover, a role of ASICs in mediating the cellular response to an ischemic insult was suggested (72). Our findings of increased inhibitory constants for Ca2+ under acidic pH support this possibility. Acidic pH can override the inhibitory influence of Ca2+ on BNaCs, converting the channel to be less selective and more resistant to Ca2+. If the neuroprotective role of acidosis is due to N-methyl-D-aspartate receptor inhibition (73), its adverse impact may arise from relief of the inhibitory influence of Ca2+ on BNaCs.

Because Ca2+ is such an effective blocker of BNaC-2, reducing cis or intracellular [Ca2+] to values <1 µM (typical [Ca2+] found within mammalian cells) would result in BNaC-2 being constitutively activated in the absence of other extrinsic or intrinsic regulators of channel function. This observation has important implications for the physiological role of this channel, particularly for high-grade glioma cells, where BNaCs appear to be open (74). Interestingly, when WT BNaC-2 cRNA was injected into and heterogeneously expressed in Xenopus oocytes, channel activity could be activated only by extracellular acid. Intracellular [Ca2+] is known to exceed 10 µM and to be as high as 30 µM in oocytes (75), which, extrapolating from the present results, would result in a channel that is constitutively closed. Our bilayer data suggest that the channel can be activated by low pH just as in the case of oocytes. As the actual molecular composition of these ion channels is unknown, this hypothesis awaits further experimentation.

The absence of cytoskeletal elements in our bilayer experiments can account for the lack of effect of Ca2+ on unitary currents of BNaC-2. Indeed, we did observe an almost 2-fold reduction of BNaC-2 single channel conductance in the presence of actin.2 These effects of actin on BNaC-2 were identical to those of actin on ENaC single channel conductance in bilayers (76, 77). Moreover, the effects of actin on the single channel conductance of ENaC were evident only in the presence of Ca2+ (78).

In summary, we have successfully reconstituted amiloride-sensitive brain sodium channels in planar lipid bilayer membranes. Our results show that these channels can be activated by low pH, that amiloride blocks these channels with a relatively low affinity, and that the activity of both WT BNaC-2 and constitutively activated BNaC-2 can be modulated by both cis and trans Ca2+. Lowering the pH decreased the effectiveness of Ca2+ in blocking these channels. We suggest that relief of the Ca2+ block of BNaCs by acidic pH in vivo may result in a cellular osmotic imbalance, ultimately leading to degeneration of the cell.

    ACKNOWLEDGEMENTS

We gratefully acknowledge Drs. D. P. Corey and J. García-Añoveros (Department of Neurobiology, Harvard Medical School, and the Howard Hughes Medical Institute) for the kind gift of BNaC cDNA. We thank Isabel Quinones for outstanding editorial assistance.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants DK 37206 and DK 56095.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| Present address: ResGen, Huntsville, AL 35801.

** To whom correspondence should be addressed: Dept. of Physiology and Biophysics, University of Alabama at Birmingham, 1918 University Blvd., MCLM 704, Birmingham, AL 35294-0005. Tel.: 205-934-6220; Fax: 205-934-2377; E-mail: benos@physiology.uab.edu.

Published, JBC Papers in Press, August 20, 2001, DOI 10.1074/jbc.M107266200

2 B. K. Berdiev, L. A. McLean, B. Jovov, T. B. Mapstone, J. M. Markert, G. Y. Gillespie, K. L. Kirk, A. Naren, C. M. Fuller, and D. J. Benos, unpublished observation.

    ABBREVIATIONS

The abbreviations used are: ENaC, epithelial Na+ channel; ASIC, acid-sensing ion channel; BNaC, brain Na+ channel; WT, wild-type; GF, gain-of function; MOPS, 3-(N-morpholino)propanesulfonic acid; MDEG, mammalian degenerin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Benos, D. J. (1982) Am. J. Physiol. 242, C131-C145[Abstract/Free Full Text]
2. Garty, H., and Benos, D. J. (1988) Physiol. Rev. 68, 309-373[Abstract/Free Full Text]
3. Canessa, C. M., Horisberger, J. D., and Rossier, B. C. (1993) Nature 361, 467-470[CrossRef][Medline] [Order article via Infotrieve]
4. Lingueglia, E., Voilley, N., Waldmann, R., Lazdunski, M., and Barbry, P. (1993) FEBS Lett. 318, 95-99[CrossRef][Medline] [Order article via Infotrieve]
5. Corey, D. P., and García-Añoveros, J. (1996) Science 273, 323-324[Medline] [Order article via Infotrieve]
6. García-Añoveros, J., and Corey, D. P. (1997) Annu. Rev. Neurosci. 20, 567-594[CrossRef][Medline] [Order article via Infotrieve]
7. Alvarez de la Rosa, D., Canessa, C. M., Fyfe, G. K., and Zhang, P. (2000) Annu. Rev. Physiol. 62, 573-594[CrossRef][Medline] [Order article via Infotrieve]
8. Waldmann, R., and Lazdunski, M. (1998) Curr. Opin. Neurobiol. 8, 418-424[CrossRef][Medline] [Order article via Infotrieve]
9. Shimkets, R. A., Warnock, D. G., Bositis, C. M., Nelson-Williams, C., Hansson, J. H., Schambelan, M., Gill, J. R., Jr., Ulick, S., Milora, R. V., Findling, J. W., Canessa, C. M., Rossier, B. C., and Lifton, R. P. (1994) Cell 79, 407-414[CrossRef][Medline] [Order article via Infotrieve]
10. Hansson, J. H., Nelson-Williams, C., Suzuki, H., Schild, L., Shimkets, R., Lu, Y., Canessa, C., Iwasaki, T., Rossier, B., and Lifton, R. P. (1995) Nat. Genet. 11, 76-82[CrossRef][Medline] [Order article via Infotrieve]
11. Hansson, J. H., Schild, L., Lu, Y., Wilson, T. A., Gautschi, I., Shimkets, R., Nelson-Williams, C., Rossier, B. C., and Lifton, R. P. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11495-11499[Abstract/Free Full Text]
12. Schild, L., Canessa, C. M., Shimkets, R. A., Gautschi, I., Lifton, R. P., and Rossier, B. C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5699-5703[Abstract/Free Full Text]
13. Chang, S. S., Grunder, S., Hanukoglu, A., Rosler, A., Mathew, P. M., Hanukoglu, I., Schild, L., Lu, Y., Shimkets, R. A., Nelson-Williams, C., Rossier, B. C., and Lifton, R. P. (1996) Nat. Genet. 12, 248-253[CrossRef][Medline] [Order article via Infotrieve]
14. Schaedel, C., Marthinsen, L., Kristoffersson, A. C., Kornfalt, R., Nilsson, K. O., Orlenius, B., and Holmberg, L. (1999) J. Pediatr. 135, 739-745[CrossRef][Medline] [Order article via Infotrieve]
15. Strautnieks, S. S., Thompson, R. J., Gardiner, R. M., and Chung, E. (1996) Nat. Genet. 13, 248-250[CrossRef][Medline] [Order article via Infotrieve]
16. Stutts, M. J., Canessa, C. M., Olsen, J. C., Hamrick, M., Cohn, J. A., Rossier, B. C., and Boucher, R. C. (1995) Science 269, 847-850[Abstract/Free Full Text]
17. Berdiev, B. K., and Ismailov, I. I. (1999) Curr. Top. Membr. 47, 351-380[CrossRef]
18. O'Brodovich, H. M. (1996) Proc. Assoc. Am. Physicians 108, 345-355[Medline] [Order article via Infotrieve]
19. Kunzelmann, K., Beesley, A. H., King, N. J., Karupiah, G., Young, J. A., and Cook, D. I. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 10282-10287[Abstract/Free Full Text]
20. García-Añoveros, J., Derfler, B., Neville-Golden, J., Hyman, B. T., and Corey, D. P. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1459-1464[Abstract/Free Full Text]
21. Price, M. P., Snyder, P. M., and Welsh, M. J. (1996) J. Biol. Chem. 271, 7879-7882[Abstract/Free Full Text]
22. Waldmann, R., Champigny, G., Voilley, N., Lauritzen, I., and Lazdunski, M. (1996) J. Biol. Chem. 271, 10433-10436[Abstract/Free Full Text]
23. Ishibashi, K., and Marumo, F. (1998) Biochem. Biophys. Res. Commun. 245, 589-593[CrossRef][Medline] [Order article via Infotrieve]
24. Babinski, K., Le, K. T., and Seguela, P. (1999) J. Neurochem. 72, 51-57[CrossRef][Medline] [Order article via Infotrieve]
25. Gründer, S., Geissler, H. S., Bassler, E. L., and Ruppersberg, J. P. (2000) Neuroreport 11, 1607-1611[Medline] [Order article via Infotrieve]
26. Waldmann, R., Champigny, G., Lingueglia, E., de Weille, J. R., Heurteaux, C., and Lazdunski, M. (1999) Ann. N. Y. Acad. Sci. 868, 67-76[CrossRef][Medline] [Order article via Infotrieve]
27. Price, M. P., Lewin, G. R., McIlwrath, S. L., Cheng, C., Xie, J., Heppenstall, P. A., Stucky, C. L., Mannsfeldt, A. G., Brennan, T. J., Drummond, H. A., Qiao, J., Benson, C. J., Tarr, D. E., Hrstka, R. F., Yang, B., Williamson, R. A., and Welsh, M. J. (2000) Nature 407, 1007-1011[CrossRef][Medline] [Order article via Infotrieve]
28. García-Añoveros, J., Samad, T. A., Woolf, C. J., and Corey, D. P. (2001) J. Neurosci. 21, 2678-2686[Abstract/Free Full Text]
29. Brooks, S. P., and Storey, K. B. (1992) Anal. Biochem. 201, 119-126[CrossRef][Medline] [Order article via Infotrieve]
30. Ismailov, I. I., Shlyonsky, V. G., Alvarez, O., and Benos, D. J. (1997) J. Physiol. (Lond.) 504, 287-300[Abstract/Free Full Text]
31. Ji, H. L., Fuller, C. M., and Benos, D. J. (1999) J. Biol. Chem. 274, 37693-37704[Abstract/Free Full Text]
32. Ji, H. L., Chalfant, M. L., Jovov, B., Lockhart, J. P., Parker, S. B., Fuller, C. M., Stanton, B. A., and Benos, D. J. (2000) J. Biol. Chem. 275, 27947-27956[Abstract/Free Full Text]
33. Jovov, B., Tousson, A., Ji, H. L., Keeton, D., Shlyonsky, V., Ripoll, P. J., Fuller, C. M., and Benos, D. J. (1999) J. Biol. Chem. 274, 37845-37854[Abstract/Free Full Text]
34. Perez, G., Lagrutta, A., Adelman, J. P., and Toro, L. (1994) Biophys. J. 66, 1022-1027[Medline] [Order article via Infotrieve]
35. Garty, H., and Palmer, L. G. (1997) Physiol. Rev. 77, 359-396[Abstract/Free Full Text]
36. Benos, D. J., Awayda, M. S., Ismailov, I. I., and Johnson, J. P. (1995) J. Membr. Biol. 143, 1-18[Medline] [Order article via Infotrieve]
37. Benos, D. J., Awayda, M. S., Berdiev, B. K., Bradford, A. L., Fuller, C. M., Senyk, O., and Ismailov, I. I. (1996) Kidney Int. 49, 1632-1637[Medline] [Order article via Infotrieve]
38. Chalfie, M., and Wolinsky, E. (1990) Nature 345, 410-416[CrossRef][Medline] [Order article via Infotrieve]
39. Driscoll, M., and Chalfie, M. (1991) Nature 349, 588-593[CrossRef][Medline] [Order article via Infotrieve]
40. García-Añoveros, J., Ma, C., and Chalfie, M. (1995) Curr. Biol. 5, 441-448[CrossRef][Medline] [Order article via Infotrieve]
41. García-Añoveros, J., Garcia, J. A., Liu, J. D., and Corey, D. P. (1998) Neuron 20, 1231-1241[CrossRef][Medline] [Order article via Infotrieve]
42. Huang, M., and Chalfie, M. (1994) Nature 367, 467-470[CrossRef][Medline] [Order article via Infotrieve]
43. Shreffler, W., Magardino, T., Shekdar, K., and Wolinsky, E. (1995) Genetics 139, 1261-1272[Abstract]
44. Tavernarakis, N., Shreffler, W., Wang, S., and Driscoll, M. (1997) Neuron 18, 107-119[CrossRef][Medline] [Order article via Infotrieve]
45. Adams, C. M., Snyder, P. M., Price, M. P., and Welsh, M. J. (1998) J. Biol. Chem. 273, 30204-30207[Abstract/Free Full Text]
46. Adams, C. M., Price, M. P., Snyder, P. M., and Welsh, M. J. (1999) Biophys. J. 76, 1377-1383[Medline] [Order article via Infotrieve]
47. Champigny, G., Voilley, N., Waldmann, R., and Lazdunski, M. (1998) J. Biol. Chem. 273, 15418-15422[Abstract/Free Full Text]
48. Silver, R. B., Frindt, G., Windhager, E. E., and Palmer, L. G. (1993) Am. J. Physiol. 264, F557-F564[Abstract/Free Full Text]
49. Ismailov, I. I., Berdiev, B. K., and Benos, D. J. (1995) J. Gen. Physiol. 106, 445-466[Abstract/Free Full Text]
50. Ismailov, I. I., Berdiev, B. K., Shlyonsky, V. G., and Benos, D. J. (1997) Biophys. J. 72, 1182-1192[Medline] [Order article via Infotrieve]
51. Ishikawa, T., Marunaka, Y., and Rotin, D. (1998) J. Gen. Physiol. 111, 825-846[Abstract/Free Full Text]
52. Woodhull, A. M. (1973) J. Gen. Physiol. 61, 687-708[Abstract/Free Full Text]
53. Coscoy, S., de Weille, J. R., Lingueglia, E., and Lazdunski, M. (1999) J. Biol. Chem. 274, 10129-10132[Abstract/Free Full Text]
54. McLaughlin, S. (1977) Curr. Top. Membr. 9, 71-144[CrossRef]
55. de Weille, J. R., Bassilana, F., Lazdunski, M., and Waldmann, R. (1998) FEBS Lett. 433, 257-260[CrossRef][Medline] [Order article via Infotrieve]
56. Bassilana, F., Champigny, G., Waldmann, R., de Weille, J. R., Heurteaux, C., and Lazdunski, M. (1997) J. Biol. Chem. 272, 28819-28822[Abstract/Free Full Text]
57. Babinski, K., Catarsi, S., Biagini, G., and Seguela, P. (2000) J. Biol. Chem. 275, 28519-28525[Abstract/Free Full Text]
58. Lingueglia, E., de Weille, J. R., Bassilana, F., Heurteaux, C., Sakai, H., Waldmann, R., and Lazdunski, M. (1997) J. Biol. Chem. 272, 29778-29783[Abstract/Free Full Text]
59. Adams, C. M., Anderson, M. G., Motto, D. G., Price, M. P., Johnson, W. A., and Welsh, M. J. (1998) J. Cell Biol. 140, 143-152[Abstract/Free Full Text]
60. Adams, C. M., Snyder, P. M., and Welsh, M. J. (1999) J. Biol. Chem. 274, 15500-15504[Abstract/Free Full Text]
61. Waldmann, R., Champigny, G., Bassilana, F., Heurteaux, C., and Lazdunski, M. (1997) Nature 386, 173-177[CrossRef][Medline] [Order article via Infotrieve]
62. Sutherland, S. P., Benson, C. J., Adelman, J. P., and McCleskey, E. W. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 711-716[Abstract/Free Full Text]
63. Chen, C. C., England, S., Akopian, A. N., and Wood, J. N. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 10240-10245[Abstract/Free Full Text]
64. Zhang, P., and Canessa, C. M. (2001) J. Gen. Physiol. 117, 563-572[Abstract/Free Full Text]
65. de Weille, J., and Bassilana, F. (2001) Brain Res. 900, 277-281[CrossRef][Medline] [Order article via Infotrieve]
66. Palmer, L. G., and Frindt, G. (1987) Am. J. Physiol. 253, F333-F339[Abstract/Free Full Text]
67. Ling, B. N., and Eaton, D. C. (1989) Am. J. Physiol. 256, F1094-F1103[Abstract/Free Full Text]
68. Siesjo, B. K., Katsura, K. I., Kristian, T., Li, P. A., and Siesjo, P. (1996) Acta Neurochir. Suppl. 66, 8-14[Medline] [Order article via Infotrieve]
69. Tombaugh, G. C., and Sapolsky, R. M. (1993) J. Neurochem. 61, 793-803[Medline] [Order article via Infotrieve]
70. Kristian, T., and Siesjo, B. K. (1998) Stroke 29, 705-718[Abstract/Free Full Text]
71. Tymianski, M., and Tator, C. H. (1996) Neurosurgery (Baltimore) 38, 1176-1195[CrossRef][Medline] [Order article via Infotrieve]
72. Johnson, M. B., Jin, K. L., Minami, M., Chen, D., and Simon, R. P. (2001) J. Cereb. Blood Flow Metab. 21, 734-740[CrossRef][Medline] [Order article via Infotrieve]
73. Kaku, D. A., Giffard, R. G., and Choi, D. W. (1993) Science 260, 1516-1518[Abstract/Free Full Text]
74. Bubien, J. K., Keeton, D. A., Fuller, C. M., Gillespie, G. Y., Reddy, A. T., Mapstone, T. B., and Benos, D. J. (1999) Am. J. Physiol. 276, C1405-C1410[Abstract/Free Full Text]
75. Dascal, N. (1987) CRC Crit. Rev. Biochem. 22, 317-387[Medline] [Order article via Infotrieve]
76. Berdiev, B. K., Prat, A. G., Cantiello, H. F., Ausiello, D. A., Fuller, C. M., Jovov, B., Benos, D. J., and Ismailov, I. I. (1996) J. Biol. Chem. 271, 17704-17710[Abstract/Free Full Text]
77. Ismailov, I. I., Berdiev, B. K., Shlyonsky, V. G., Fuller, C. M., Prat, A. G., Jovov, B., Cantiello, H. F., Ausiello, D. A., and Benos, D. J. (1997) Am. J. Physiol. 272, C1077-C1086[Abstract/Free Full Text]
78. Berdiev, B. K., Latorre, R., Benos, D. J., and Ismailov, I. I. (2001) Biophys. J. 80, 2176-2186[Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. J. Qadri, B. K. Berdiev, Y. Song, H. L. Lippton, C. M. Fuller, and D. J. Benos
Psalmotoxin-1 Docking to Human Acid-sensing Ion Channel-1
J. Biol. Chem., June 26, 2009; 284(26): 17625 - 17633.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. C. Askwith, J. A. Wemmie, M. P. Price, T. Rokhlina, and M. J. Welsh
Acid-sensing Ion Channel 2 (ASIC2) Modulates ASIC1 H+-activated Currents in Hippocampal Neurons
J. Biol. Chem., April 30, 2004; 279(18): 18296 - 18305.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Berdiev, J. Xia, L. A. McLean, J. M. Markert, G. Y. Gillespie, T. B. Mapstone, A. P. Naren, B. Jovov, J. K. Bubien, H.-L. Ji, et al.
Acid-sensing Ion Channels in Malignant Gliomas
J. Biol. Chem., April 18, 2003; 278(17): 15023 - 15034.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
D. J. Brat and T. B. Mapstone
Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression
Ann Intern Med, April 15, 2003; 138(8): 659 - 668.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. S. Leonard, O. Yermolaieva, A. Hruska-Hageman, C. C. Askwith, M. P. Price, J. A. Wemmie, and M. J. Welsh
cAMP-dependent protein kinase phosphorylation of the acid-sensing ion channel-1 regulates its binding to the protein interacting with C-kinase-1
PNAS, February 18, 2003; 100(4): 2029 - 2034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Berdiev, J. Xia, B. Jovov, J. M. Markert, T. B. Mapstone, G. Y. Gillespie, C. M. Fuller, J. K. Bubien, and D. J. Benos
Protein Kinase C Isoform Antagonism Controls BNaC2 (ASIC1) Function
J. Biol. Chem., November 22, 2002; 277(48): 45734 - 45740.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
P. Zhang and C. M. Canessa
Single Channel Properties of Rat Acid-sensitive Ion Channel-1{alpha}, -2a, and -3 Expressed in Xenopus Oocytes
J. Gen. Physiol., September 30, 2002; 120(4): 553 - 566.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. J. Drew, J. N. Wood, and P. Cesare
Distinct Mechanosensitive Properties of Capsaicin-Sensitive and -Insensitive Sensory Neurons
J. Neurosci., May 31, 2002; (2002) 20026459.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-L. Ji, B. Jovov, J. Fu, L. R. Bishop, H. C. Mebane, C. M. Fuller, B. A. Stanton, and D. J. Benos
Up-regulation of Acid-gated Na+ Channels (ASICs) by Cystic Fibrosis Transmembrane Conductance Regulator Co-expression in Xenopus Oocytes
J. Biol. Chem., March 1, 2002; 277(10): 8395 - 8405.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/42/38755    most recent
M107266200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berdiev, B. K.
Right arrow Articles by Benos, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berdiev, B. K.
Right arrow Articles by Benos, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement